Pharmacogenetics of Oxaliplatin as Adjuvant Treatment in Colon Carcinoma: Are Single Nucleotide Polymorphisms in GSTP1, ERCC1, and ERCC2 Good Predictive Markers?

Author: Sarasqueta Arantza Fariña   >  

Publisher: Adis International

ISSN: 1177-1062

Source: Molecular Diagnosis & Therapy, Vol.15, Iss.5, 2011-10, pp. : 277-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract